Treatment of Moderate to Severe Refractory Crohn's Disease

Summary

This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.

Timeline

Start

2025-05-05

Primary completion

2026-01-30

Completion

2027-01-30

Drugs

Indications